Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacodynamics Study”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00840320
What this trial is testing

Repeat Dose Safety Study for Compound to Treat Anemia

Who this might be right for
Kidney Disease
GlaxoSmithKline 24
Early research (Phase 1)Study completedNCT03001297
What this trial is testing

Phase 1, Single Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of MEDI5884

Who this might be right for
Healthy Volunteers
MedImmune LLC 64
Early research (Phase 1)Study completedNCT02524782
What this trial is testing

A Phase 1, Single- and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MEDI4166 in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
MedImmune LLC 103
Large-scale testing (Phase 3)Looking for participantsNCT06055959
What this trial is testing

Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 8
Testing effectiveness (Phase 2)Study completedNCT02750618
What this trial is testing

Study of the Safety, Pharmacodynamics (PD) and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)

Who this might be right for
X-Linked Hypophosphatemia
Kyowa Kirin, Inc. 13
Early research (Phase 1)Looking for participantsNCT06606990
What this trial is testing

Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers

Who this might be right for
Metastatic Malignant Solid Neoplasm
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Looking for participantsNCT07557420
What this trial is testing

Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
NMOSDNeuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 19
Testing effectiveness (Phase 2)Looking for participantsNCT06546670
What this trial is testing

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Novartis Pharmaceuticals 161
Early research (Phase 1)Ended earlyNCT04691375
What this trial is testing

PY314 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorGynecologic CancerBreast Cancer+6 more
Ikena Oncology 86
Early research (Phase 1)Study completedNCT00946257
What this trial is testing

Subcutaneous Administration of Otelixizumab to T1DM Patients

Who this might be right for
Diabetes Mellitus, Type 1
GlaxoSmithKline 33
Testing effectiveness (Phase 2)Study completedNCT00989014
What this trial is testing

Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea

Who this might be right for
Erythematotelangiectatic Rosacea
Galderma R&D 122
Testing effectiveness (Phase 2)Study completedNCT04497116
What this trial is testing

Study of RP-3500, Camonsertib, in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Repare Therapeutics 276
Early research (Phase 1)Study completedNCT01549106
What this trial is testing

IPI-145 Single Ascending, Multiple Ascending, Food Effect and Drug-Drug-Interaction Study

Who this might be right for
Healthy Volunteers
SecuraBio 106
Testing effectiveness (Phase 2)Study completedNCT06471530
What this trial is testing

Investigate the Safety and Tolerability of TE-8105 in Overweight/Obese Participants Without Diabetes

Who this might be right for
Overweight and Obesity
Immunwork, Inc. 38
Testing effectiveness (Phase 2)Ended earlyNCT02154087
What this trial is testing

Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers

Who this might be right for
Venous Leg Ulcers
Healthpoint 1
Testing effectiveness (Phase 2)Looking for participantsNCT07646587
What this trial is testing

WIN378 in Participants With Moderate to Severe COPD (Sirius)

Who this might be right for
COPD (Chronic Obstructive Pulmonary Disease)
Windward Bio 105
Testing effectiveness (Phase 2)Study completedNCT00392587
What this trial is testing

Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease)

Who this might be right for
Pulmonary Disease, Chronic ObstructiveChronic Obstructive Pulmonary Disease (COPD)
GlaxoSmithKline 30
Early research (Phase 1)Study completedNCT01892384
What this trial is testing

Safety and Tolerability of BI 409306 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Boehringer Ingelheim 40
Early research (Phase 1)Looking for participantsNCT07760467
What this trial is testing

To Evaluate Safety, Tolerability, PK/PD & Food Effect of Single/Multiple Oral TUL321 Capsules in Healthy Participants.

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria, PNH
Zhuhai United Laboratories Co., Ltd. 94
Testing effectiveness (Phase 2)Looking for participantsNCT06209736
What this trial is testing

Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN

Who this might be right for
C3 GlomerulopathyIdiopathic Immune Complex-Mediated Glomerulonephritis
Omeros Corporation 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation